• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟、肥胖与巴雷特食管中胃酸反流症状之间的相互作用。

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.

作者信息

Smith Kylie J, O'Brien Suzanne M, Smithers B Mark, Gotley David C, Webb Penelope M, Green Adèle C, Whiteman David C

机构信息

Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia.

出版信息

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2481-6. doi: 10.1158/1055-9965.EPI-05-0370.

DOI:10.1158/1055-9965.EPI-05-0370
PMID:16284367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1481636/
Abstract

BACKGROUND

Barrett's esophagus, a metaplastic precursor to esophageal adenocarcinoma, is becoming increasingly prevalent in many populations. Clinical studies suggest acid reflux causes Barrett's esophagus; however, no population-based estimates of risk have been reported, and the role of other health factors in modifying risk is unclear.

METHODS

We conducted a population-based case-control study in Brisbane, Australia. Cases were 167 patients with histologically confirmed Barrett's esophagus diagnosed between February and December 2003. Age-matched and sex-matched controls (n = 261) were randomly selected from a population register. Data on exposure to self-reported symptoms of acid reflux, smoking, obesity, and other factors were collected through self-completed questionnaires followed by telephone interview. Risks of Barrett's esophagus and Barrett's esophagus with dysplasia associated with these exposures were estimated by the odds ratio (OR) and 95% confidence interval (95% CI), both crude and adjusted for other factors.

RESULTS

Self-reported weekly episodes of acid reflux were associated with greatly increased risks of Barrett's esophagus (adjusted OR, 29.7; 95% CI, 12.2-72.6) and Barrett's esophagus with dysplasia (OR, 59.7; 95% CI, 18.5-193). Smoking was also associated with risk of Barrett's esophagus. We found evidence of interactions between symptoms of acid reflux and smoking and obesity. Obese people with self-reported symptoms of acid reflux had markedly higher risks of Barrett's esophagus (OR, 34.4; 95% CI, 6.3-188) than people with reflux alone (OR, 9.3; 95% CI, 1.4-62.2) or obesity alone (OR, 0.7; 95% CI, 0.2-2.4). Similarly, those reporting both acid reflux symptoms and smoking were at substantially higher risks of Barrett's esophagus (OR, 51.4; 95% CI, 14.1-188) than those reporting acid reflux or smoking alone.

CONCLUSIONS

Although history of symptoms of acid reflux is the principle factor associated with Barrett's esophagus, risks are substantially increased by obesity and smoking.

摘要

背景

巴雷特食管是食管腺癌的一种化生前驱病变,在许多人群中越来越普遍。临床研究表明胃酸反流会导致巴雷特食管;然而,尚未有基于人群的风险估计报告,且其他健康因素在改变风险方面的作用尚不清楚。

方法

我们在澳大利亚布里斯班进行了一项基于人群的病例对照研究。病例为2003年2月至12月间经组织学确诊的167例巴雷特食管患者。年龄和性别匹配的对照(n = 261)从人口登记册中随机选取。通过自行填写问卷并随后进行电话访谈收集关于自我报告的胃酸反流症状、吸烟、肥胖及其他因素暴露的数据。通过比值比(OR)和95%置信区间(95%CI)估计与这些暴露相关的巴雷特食管及发育异常的巴雷特食管的风险,包括粗风险和经其他因素调整后的风险。

结果

自我报告每周出现胃酸反流发作与巴雷特食管风险大幅增加相关(调整后的OR,29.7;95%CI,12.2 - 72.6)以及与发育异常的巴雷特食管相关(OR,59.7;95%CI,18.5 - 193)。吸烟也与巴雷特食管风险相关。我们发现胃酸反流症状与吸烟及肥胖之间存在相互作用的证据。自我报告有胃酸反流症状的肥胖者患巴雷特食管的风险(OR,34.4;95%CI,6.3 - 188)明显高于仅患有反流者(OR,9.3;95%CI,1.4 - 62.2)或仅肥胖者(OR,0.7;95%CI,0.2 - 2.4)。同样,那些同时报告有胃酸反流症状和吸烟的人患巴雷特食管的风险(OR,51.4;95%CI,14.1 - 188)明显高于仅报告有胃酸反流或吸烟的人。

结论

虽然胃酸反流症状史是与巴雷特食管相关的主要因素,但肥胖和吸烟会大幅增加风险。

相似文献

1
Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.吸烟、肥胖与巴雷特食管中胃酸反流症状之间的相互作用。
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2481-6. doi: 10.1158/1055-9965.EPI-05-0370.
2
Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study.一项基于人群的病例对照研究:阻塞性睡眠呼吸暂停、胃食管反流症状与巴雷特食管风险
PLoS One. 2015 Jun 19;10(6):e0129836. doi: 10.1371/journal.pone.0129836. eCollection 2015.
3
Risk factors for Barrett's esophagus.巴雷特食管的危险因素。
Curr Opin Gastroenterol. 2014 Jul;30(4):408-14. doi: 10.1097/MOG.0000000000000084.
4
Leptin and the risk of Barrett's oesophagus.瘦素与巴雷特食管的风险
Gut. 2008 Apr;57(4):448-54. doi: 10.1136/gut.2007.131243. Epub 2008 Jan 4.
5
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.吸烟增加巴雷特食管风险:巴雷特食管和食管腺癌联盟分析。
Gastroenterology. 2012 Apr;142(4):744-53. doi: 10.1053/j.gastro.2011.12.049. Epub 2012 Jan 11.
6
Risk factors in the development of esophageal adenocarcinoma.食管腺癌发展的危险因素。
Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18.
7
Association between the body mass index and the risk of Barrett's esophagus in Japan.日本体重指数与巴雷特食管风险之间的关联。
Digestion. 2014;90(1):1-9. doi: 10.1159/000357776. Epub 2014 Jul 29.
8
A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.FOXP1基因附近新发现的一个易感位点改变了胃食管反流与巴雷特食管之间的关联。
Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1739-47. doi: 10.1158/1055-9965.EPI-15-0507. Epub 2015 Sep 16.
9
Risk factors, DNA damage, and disease progression in Barrett's esophagus.巴雷特食管的危险因素、DNA损伤与疾病进展
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5. doi: 10.1158/1055-9965.EPI-04-0509.
10
Barrett's esophagus and medications that relax the lower esophageal sphincter.巴雷特食管与使食管下括约肌松弛的药物。
Am J Gastroenterol. 2006 May;101(5):937-44. doi: 10.1111/j.1572-0241.2006.00539.x.

引用本文的文献

1
Gender disparities and woman-specific trends in Barrett's esophagus in the United States: An 11-year nationwide population-based study.美国巴雷特食管的性别差异及女性特有趋势:一项基于全国人口的11年研究。
World J Methodol. 2025 Mar 20;15(1):97512. doi: 10.5662/wjm.v15.i1.97512.
2
Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.巴雷特食管和食管腺癌发生的危险因素:一项系统评价和荟萃分析
Cancer Rep (Hoboken). 2025 Mar;8(3):e70168. doi: 10.1002/cnr2.70168.
3
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study.胃食管反流病患者发展为 Barrett 食管的长期风险因素:一项纵向队列研究。
BMJ Open Gastroenterol. 2024 Mar 22;11(1):e001307. doi: 10.1136/bmjgast-2023-001307.
4
Burden of esophageal cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.2019 年全球 204 个国家和地区食管癌发病和死亡负担及其归因危险因素分析。
Front Public Health. 2022 Sep 6;10:952087. doi: 10.3389/fpubh.2022.952087. eCollection 2022.
5
A risk variant for Barrett's esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets.8p23.1 上的 Barrett 食管和食管腺癌风险变异影响增强子活性并涉及多个基因靶点。
Hum Mol Genet. 2022 Nov 28;31(23):3975-3986. doi: 10.1093/hmg/ddac141.
6
Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.GWAS 风险位点在巴雷特食管和食管腺癌中的优先级和功能分析。
Hum Mol Genet. 2022 Feb 3;31(3):410-422. doi: 10.1093/hmg/ddab259.
7
Development of EndoScreen Chip, a Microfluidic Pre-Endoscopy Triage Test for Esophageal Adenocarcinoma.用于食管腺癌的微流控内镜前分诊检测——EndoScreen芯片的研发
Cancers (Basel). 2021 Jun 8;13(12):2865. doi: 10.3390/cancers13122865.
8
MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C.微小 RNA-2053 通过靶向 KIF3C 参与食管癌的进展。
Cell Cycle. 2021 Jun;20(12):1163-1172. doi: 10.1080/15384101.2021.1929675. Epub 2021 May 31.
9
Liver X Receptor β Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer.肝 X 受体 β 与甲状腺乳头状癌的肿瘤进展和核糖体基因表达相关。
Endocrinol Metab (Seoul). 2020 Sep;35(3):656-668. doi: 10.3803/EnM.2020.667. Epub 2020 Aug 20.
10
Barrett's esophagus with high grade dysplasia is associated with non-esophageal cancer.巴雷特食管伴高级别异型增生与非食管癌相关。
World J Gastroenterol. 2018 Oct 21;24(39):4472-4481. doi: 10.3748/wjg.v24.i39.4472.

本文引用的文献

1
Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community.社区中胃食管反流症状频繁发作人群的内镜检查率及内镜检查结果
Am J Gastroenterol. 2005 Jul;100(7):1459-65. doi: 10.1111/j.1572-0241.2005.41115.x.
2
Advances in Barrett's esophagus and esophageal adenocarcinoma.巴雷特食管和食管腺癌的进展
Gastroenterology. 2005 May;128(6):1554-66. doi: 10.1053/j.gastro.2005.03.032.
3
Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study.肥胖与胃肠道症状风险增加相关:一项基于人群的研究。
Am J Gastroenterol. 2004 Sep;99(9):1801-6. doi: 10.1111/j.1572-0241.2004.30887.x.
4
Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort.澳大利亚队列中上下消化道症状与体重指数的关联
Neurogastroenterol Motil. 2004 Aug;16(4):413-9. doi: 10.1111/j.1365-2982.2004.00530.x.
5
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.超重、肥胖与癌症:流行病学证据及潜在机制
Nat Rev Cancer. 2004 Aug;4(8):579-91. doi: 10.1038/nrc1408.
6
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.巴雷特食管诊断与管理的批判性综述:美国胃肠病学会芝加哥研讨会
Gastroenterology. 2004 Jul;127(1):310-30. doi: 10.1053/j.gastro.2004.04.010.
7
Contacting controls: are we working harder for similar response rates, and does it make a difference?联系对照组:我们为了相似的响应率而更加努力工作,这有区别吗?
Am J Epidemiol. 2004 Jul 1;160(1):85-90. doi: 10.1093/aje/kwh176.
8
Gastroesophageal reflux among different racial groups in the United States.美国不同种族群体中的胃食管反流。
Gastroenterology. 2004 Jun;126(7):1692-9. doi: 10.1053/j.gastro.2004.03.077.
9
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.关于:阿司匹林化学预防巴雷特食管的成本效益。
J Natl Cancer Inst. 2004 Jun 2;96(11):885-7; author reply 887. doi: 10.1093/jnci/djh171.
10
Chemoprevention for Barrett's esophagus trial. Design and outcome measures.巴雷特食管化学预防试验。设计与结局指标。
Dis Esophagus. 2003;16(3):177-86. doi: 10.1046/j.1442-2050.2003.00325.x.